Central Application of Aliskiren, a Renin Inhibitor, Improves Outcome After Experimental Stroke Independent of Its Blood Pressure Lowering Effect.

Panahpour H, Terpolilli NA, Schaffert D, Culmsee C, Plesnila N

Open source

DOI
10.3389/fneur.2019.00942
Published
2019
Container
Frontiers in neurology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2019.00942,
  title = {Central Application of Aliskiren, a Renin Inhibitor, Improves Outcome After Experimental Stroke Independent of Its Blood Pressure Lowering Effect.},
  author = {Panahpour H and Terpolilli NA and Schaffert D and Culmsee C and Plesnila N},
  year = {2019},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2019.00942},
  url = {https://doi.org/10.3389/fneur.2019.00942}
}

RIS

TY  - JOUR
TI  - Central Application of Aliskiren, a Renin Inhibitor, Improves Outcome After Experimental Stroke Independent of Its Blood Pressure Lowering Effect.
AU  - Panahpour H
AU  - Terpolilli NA
AU  - Schaffert D
AU  - Culmsee C
AU  - Plesnila N
PY  - 2019
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2019.00942
UR  - https://doi.org/10.3389/fneur.2019.00942
ER  - 

APA

H, P., NA, T., D, S., C, C., & N, P. (2019). Central Application of Aliskiren, a Renin Inhibitor, Improves Outcome After Experimental Stroke Independent of Its Blood Pressure Lowering Effect.. Frontiers in neurology. https://doi.org/10.3389/fneur.2019.00942

Source records